MedPath
NMPA Approval

Meropenem for Injection

国药准字H20243623

April 30, 2024

Drug Information

注射用美罗培南

注射剂

0.5g(以C₁₇H₂₅N₃O₅S计)

化学药品

April 30, 2024

Company Information

Applicant Company

中国(江苏)自由贸易试验区苏州片区苏州工业园区华云路1号东坊产业园C区8号楼5楼

Manufacturing Company

山东省临沂高新技术产业开发区罗七路

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.